Destiny Pharma’s Call to Arms to Combat AMR
CEO Neil Clark and CSO Dr Bill Love from Europe’s leading anti-infectives biotech company Destiny Pharma, on how the makers and influencers of health policy could fuel a renaissance in drug development…
Tag Archive for: AMR Action Fund
